Stay updated on ACTIMIS: Acute Stroke Intervention Clinical Trial
Sign up to get notified when there's something new on the ACTIMIS: Acute Stroke Intervention Clinical Trial page.

Latest updates to the ACTIMIS: Acute Stroke Intervention Clinical Trial page
- CheckyesterdayChange DetectedThe error page’s footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check8 days agoChange DetectedThe site’s displayed revision changed from v3.7.0 to v3.7.1; no study details or other substantive page content changed.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous study record content.SummaryDifference0.5%

- Check29 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the previously visible study record content. The update adds the 403 HTML markup and site header/footer, and removes the study-specific details and keywords that were present before.SummaryDifference20%

- Check50 days agoChange DetectedAdded a funding note: '2018 ( U.S. NIH Grant/Contract )' and updated the revision to 'Revision: v3.6.6'. The previous revision note 'Revision: v3.6.5' was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded a new publication entry titled 'Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development' to Publications. The update also includes sponsor (Acticor Biotech) and a note about Helpful Links, expanding the page's organizational context.SummaryDifference0.2%

Stay in the know with updates to ACTIMIS: Acute Stroke Intervention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIMIS: Acute Stroke Intervention Clinical Trial page.